Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
$PVSP DESCRIPTION
We provide business consulting and marketing services to public companies. More than 100 companies have purchased space on our website https://privateequitymarkets.us/. Our website features publicly traded companies and highlights the mining, technology, bio-tech, green-tech and cannabis industries. Services include free listings of press releases and a news feed.
$PVSP Pervasip owns 100% of Artizen Corporation (“Artizen Corp”). Artizen Corp’s wholly owned subsidiary, Zen Asset Management LLC (“ZAM”) is a foundational operator that provides the basis for our cannabis related investments. ZAM, a diversified asset management company was founded to acquire, develop, and support companies and technologies in the cannabis industry.
$NGTF HUGE NEWS as Nightfood Ice Cream is NOW Challenging Leading National Brands such as Haagen Daas in Hotel Pint Sales Just Months Into Launch, According to Impulsify POS Sales Data
https://lnkd.in/dwUJdvGS
$AITX Video out! Steve Reinharz Interviewed by Chuck Harold at GSX 2022
$PVSP Name change almost done.
NY counsel approved, currently out for shareholder consent, then off to NY for filing 😎
— Pervasip Corp (@PervasipC) September 21, 2022
$PVSP news getting big buzz: Pervasip Announces $1.6 Million in August Revenues and 3rd Quarter Guidance https://finance.yahoo.com/news/pervasip-announces-1-6-million-131500755.html?soc_src=social-sh&soc_trk=tw&tsrc=twtr via @YahooFinance
$PVSP plans to expand its national reach by adding various recreational states to its brand footprint, either via licensing agreements or through acquisitions of recreational cultivation and retail licenses
95% of revenue from Artizen’s brands has come from sales of cannabis flower, supporting its position of the 9th most sold independent flower brand in North America; acquisitions and partnerships will open access to concentrates and edible verticals representing 40% of market sales and heretofore not covered by Artizen products
Artizen projects it will generate $50 million in annualized revenues nationally by end of Q4 2024; this is a conservative estimate that does not include any potential revenue multiples from acquisition of retail opportunities.
24 Months plan detail
Rename Pervasip Corp to Artizen Corporation by year end 2022 to better reflect the new focus of the company
Change the OTC ticker symbol
Re-brand all Pervasip/Artizen assets
Continue to rationalize the business through Q1 2023 with a focus on operating margins, shedding underperforming assets, consolidating operations and focus in-house talent on higher margin operations and product lines
Acquire concentrates assets by end of 2022, launching into the highly lucrative concentrates business
Expand flower and concentrates offerings within our brands as well as adding new brands for certain product offerings and price points through Q1 2023
Complete the audit and begin the OTC QB application process during Q2 2023
Launch Artizen Wellness Q2 2023
Enter the edibles market in Q2 2023 via acquisition and partnerships
Artizen becomes an MSO with cultivation and retail assets in 1 – 2 additional states during 2nd half of 2024, beginning its state expansion in Q1 2023, initially through brand licensing opportunities and strategic partnerships, and eventually via acquisitions and mergers during Q3 and Q4 2024
Close first brand licensing agreement by end of Q4 2022
Close one brand licensing deal every quarter thereafter
Financial Outlook Q3 2022 through Q4 2023
Reach $2.0 million in monthly revenue by end of Q1 2023
Reach $2.5 million or $30 million in annualized revenue by end of Q4 2023 with 30% in adjusted EBIDTA
Reach $3.0 million or $36 million in annualized revenues by end of Q2 2024 with 35% in adjusted EBIDTA
Reach $50 million in annualized revenue with 35% in adjusted EBIDTA
$PVSP has reported that various new product lines and planned near-term acquisitions will add revenue, new growth opportunities, and be a springboard for expansion into other recreational cannabis markets in the US!
$PVSP in beautiful Port Townsend, on the northern end of the Olympic Peninsula, this gorgeous light deprivation greenhouse garden is producing beautiful flower and is home to some of the more exotic genetics in the Artizen brand. At 39,000 square feet it is the second largest of all of the gardens growing Artizen branded flower.
$PVSP is Artizen Cannabis and expanding rapidly nationwide and international markets too!
$PVSP The Company also reports that various new product lines and planned near-term acquisitions will add revenue, new growth opportunities, and be a springboard for expansion into other recreational cannabis markets in the US.
https://www.bloomberg.com/press-releases/2022-09-13/pervasip-corp-pervasip-announces-1-6-million-in-august-revenues-and-3rd-quarter-guidance
$PVSP Artizen is the 9th largest cannabis consumer brand in North America according to MJBiz Magazine, November 2022
$PVSP (“Pervasip” or the “Company”), a developer of companies and technologies in high value emerging markets, together with Zen Asset Management, today announced that Artizen reached sales of $1.6 million in August.
“Marking the best sales month ever is a testament to the hard work of the team and quality of Artizen branded products in these difficult market conditions,” says German Burtscher, Pervasip’s CEO. “August also marks the close of the 3rd quarter and the restructuring efforts of the last several months are starting to show improvement across many key financial performance indicators, including cashflow for Q3. As we further rationalize our business, including shedding of underperforming assets, we will continue to prioritize margins over revenue to build lasting financial health and strengthening fundamentals important to support our growth. We are achieving a more balanced ratio of revenues across all product categories which will serve the Company well as it goes into Q4.”
The Company also reports that various new product lines and planned near-term acquisitions will add revenue, new growth opportunities, and be a springboard for expansion into other recreational cannabis markets in the US.
$PVSP developer of companies and technologies in high value emerging markets, together with Zen Asset Management today announced its 2-year strategic roadmap.
“On the heels of Artizen Corporation’s reverse merger to acquire Pervasip Corp, the cannabis industry experienced a dramatic post pandemic contraction. Planned restructuring efforts had already launched in late 2021 and we took even more aggressive steps to further rationalize our business, dispose of undervalued assets, re-focus on higher margin products and allowed our leading brands to take a more aggressive posture to increase market share. Healthy inventory amounts provided for extraordinary financing via cashflow, albeit at extremely low margins, a carefully considered short term decision which has now come to an end as we have achieved our goals. All these efforts position us nicely for healthy financial growth in 2023. As promised, we have also finalized a 24-month roadmap and are in a position to provide carefully considered guidance in a market that is still extremely unpredictable,” said German Burtscher, Pervasip CEO. “It is also important to note that all the Artizen brands’ revenue is wholesale, revenue derived from sales to retailers. The vast majority of MSOs report revenues and resulting financials that include retail sales from stores they own in addition to usually rather small wholesale revenue, all mostly generated in protected markets. Washington State (WA) cannabis sales are taxed at 47% (!) and each dollar sold by a producer/processor is marked up 3 – 3.5 times by the retailers they sell to. Generating profitable revenue in WA will translate extremely well once our brands and operating expertise is applied in other recreational markets.”
Market Overview – Washington
The below Washington State (WA) sales by category chart provides information on how monthly sales of approximately $100 million in retail sales breaks down by product category. It might also be informative to understand that June ’22 sales over June ’19 sales (pre pandemic) show an almost 17% increase. While WA sales are slightly above other mature cannabis states (NV, CO, OR), similar increases can be seen in those markets. An exuberant pandemic triggered belief in continued rapid growth has led to over development of production infrastructure and resulted in material oversupply of bulk cannabis flower. The market is in the process of correcting and the Company estimates Q3 2023 being the end of the corrective period, resulting in strengthening prices.
$100M In Monthly Sales By Category
After several years of recreational sales, the mature markets provide relevant insights into future sales distribution across key categories with flower and pre-rolls still leading at 59%, followed by concentrates (dabs/vape) at 29% and finally edibles and beverages at a combined 9%
Artizen brands will materially expand their flower market share and enter the concentrates and edibles market with a goal of occupying top 10% market share positions in each vertical.
Strategic Outlook Summary through Q4 2024
Focus on expanding its Washington State footprint, strengthening its brand repertoire and aggressively expanding its product lineup
We expect in-state revenues generated by all brands and across all product categories to reach $30 million in annualized revenue by end of Q4 2024 with Gross Margins reaching 40% and an adjusted EBIDTA of 30%
Pervasip/Artizen Corp plans to expand its national reach by adding various recreational states to its brand footprint, either via licensing agreements or through acquisitions of recreational cultivation and retail licenses
95% of revenue from Artizen’s brands has come from sales of cannabis flower, supporting its position of the 9th most sold independent flower brand in North America; acquisitions and partnerships will open access to concentrates and edible verticals representing 40% of market sales and heretofore not covered by Artizen products
Artizen projects it will generate $50 million in annualized revenues nationally by end of Q4 2024; this is a conservative estimate that does not include any potential revenue multiples from acquisition of retail opportunities.
24 Months plan detail
Rename Pervasip Corp to Artizen Corporation by year end 2022 to better reflect the new focus of the company
Change the OTC ticker symbol
Re-brand all Pervasip/Artizen assets
Continue to rationalize the business through Q1 2023 with a focus on operating margins, shedding underperforming assets, consolidating operations and focus in-house talent on higher margin operations and product lines
Acquire concentrates assets by end of 2022, launching into the highly lucrative concentrates business
Expand flower and concentrates offerings within our brands as well as adding new brands for certain product offerings and price points through Q1 2023
Complete the audit and begin the OTC QB application process during Q2 2023
Launch Artizen Wellness Q2 2023
Enter the edibles market in Q2 2023 via acquisition and partnerships
Artizen becomes an MSO with cultivation and retail assets in 1 – 2 additional states during 2nd half of 2024, beginning its state expansion in Q1 2023, initially through brand licensing opportunities and strategic partnerships, and eventually via acquisitions and mergers during Q3 and Q4 2024
Close first brand licensing agreement by end of Q4 2022
Close one brand licensing deal every quarter thereafter
Financial Outlook Q3 2022 through Q4 2023
Reach $2.0 million in monthly revenue by end of Q1 2023
Reach $2.5 million or $30 million in annualized revenue by end of Q4 2023 with 30% in adjusted EBIDTA
Reach $3.0 million or $36 million in annualized revenues by end of Q2 2024 with 35% in adjusted EBIDTA
Reach $50 million in annualized revenue with 35% in adjusted EBIDTA
$PVSP a developer of companies and technologies in high value emerging markets, together with Zen Asset Management today announced its 2-year strategic roadmap.
“On the heels of Artizen Corporation’s reverse merger to acquire Pervasip Corp, the cannabis industry experienced a dramatic post pandemic contraction. Planned restructuring efforts had already launched in late 2021 and we took even more aggressive steps to further rationalize our business, dispose of undervalued assets, re-focus on higher margin products and allowed our leading brands to take a more aggressive posture to increase market share. Healthy inventory amounts provided for extraordinary financing via cashflow, albeit at extremely low margins, a carefully considered short term decision which has now come to an end as we have achieved our goals. All these efforts position us nicely for healthy financial growth in 2023. As promised, we have also finalized a 24-month roadmap and are in a position to provide carefully considered guidance in a market that is still extremely unpredictable,” said German Burtscher, Pervasip CEO. “It is also important to note that all the Artizen brands’ revenue is wholesale, revenue derived from sales to retailers. The vast majority of MSOs report revenues and resulting financials that include retail sales from stores they own in addition to usually rather small wholesale revenue, all mostly generated in protected markets. Washington State (WA) cannabis sales are taxed at 47% (!) and each dollar sold by a producer/processor is marked up 3 – 3.5 times by the retailers they sell to. Generating profitable revenue in WA will translate extremely well once our brands and operating expertise is applied in other recreational markets.”
Market Overview – Washington
The below Washington State (WA) sales by category chart provides information on how monthly sales of approximately $100 million in retail sales breaks down by product category. It might also be informative to understand that June ’22 sales over June ’19 sales (pre pandemic) show an almost 17% increase. While WA sales are slightly above other mature cannabis states (NV, CO, OR), similar increases can be seen in those markets. An exuberant pandemic triggered belief in continued rapid growth has led to over development of production infrastructure and resulted in material oversupply of bulk cannabis flower. The market is in the process of correcting and the Company estimates Q3 2023 being the end of the corrective period, resulting in strengthening prices.
$100M In Monthly Sales By Category
After several years of recreational sales, the mature markets provide relevant insights into future sales distribution across key categories with flower and pre-rolls still leading at 59%, followed by concentrates (dabs/vape) at 29% and finally edibles and beverages at a combined 9%
Artizen brands will materially expand their flower market share and enter the concentrates and edibles market with a goal of occupying top 10% market share positions in each vertical.
Strategic Outlook Summary through Q4 2024
Focus on expanding its Washington State footprint, strengthening its brand repertoire and aggressively expanding its product lineup
We expect in-state revenues generated by all brands and across all product categories to reach $30 million in annualized revenue by end of Q4 2024 with Gross Margins reaching 40% and an adjusted EBIDTA of 30%
Pervasip/Artizen Corp plans to expand its national reach by adding various recreational states to its brand footprint, either via licensing agreements or through acquisitions of recreational cultivation and retail licenses
95% of revenue from Artizen’s brands has come from sales of cannabis flower, supporting its position of the 9th most sold independent flower brand in North America; acquisitions and partnerships will open access to concentrates and edible verticals representing 40% of market sales and heretofore not covered by Artizen products
Artizen projects it will generate $50 million in annualized revenues nationally by end of Q4 2024; this is a conservative estimate that does not include any potential revenue multiples from acquisition of retail opportunities.
24 Months plan detail
Rename Pervasip Corp to Artizen Corporation by year end 2022 to better reflect the new focus of the company
Change the OTC ticker symbol
Re-brand all Pervasip/Artizen assets
Continue to rationalize the business through Q1 2023 with a focus on operating margins, shedding underperforming assets, consolidating operations and focus in-house talent on higher margin operations and product lines
Acquire concentrates assets by end of 2022, launching into the highly lucrative concentrates business
Expand flower and concentrates offerings within our brands as well as adding new brands for certain product offerings and price points through Q1 2023
Complete the audit and begin the OTC QB application process during Q2 2023
Launch Artizen Wellness Q2 2023
Enter the edibles market in Q2 2023 via acquisition and partnerships
Artizen becomes an MSO with cultivation and retail assets in 1 – 2 additional states during 2nd half of 2024, beginning its state expansion in Q1 2023, initially through brand licensing opportunities and strategic partnerships, and eventually via acquisitions and mergers during Q3 and Q4 2024
Close first brand licensing agreement by end of Q4 2022
Close one brand licensing deal every quarter thereafter
Financial Outlook Q3 2022 through Q4 2023
Reach $2.0 million in monthly revenue by end of Q1 2023
Reach $2.5 million or $30 million in annualized revenue by end of Q4 2023 with 30% in adjusted EBIDTA
Reach $3.0 million or $36 million in annualized revenues by end of Q2 2024 with 35% in adjusted EBIDTA
Reach $50 million in annualized revenue with 35% in adjusted EBIDTA
$PVSP Our focus is on developing and investing in companies and technologies in high value emerging markets, specifically Cannabis and Medical Fungi. We look for investments in operators who will become the foundational base for growth in each segment and related technologies and research assets that can support near term and future expansion.
https://www.pervasip.net/about
$AITX News: AITX's Subsidiary Robotic Assistance Devices Concludes GSX 2022 With Pre-Orders for 30 RIO Portable Solar Powered Security Towers
September 15, 2022 (Globe Newswire)
EQNX::TICKER_START (Other OTC:AITX),(OTC US:AITX), EQNX::TICKER_END Artificial Intelligence Technology Solutions, Inc., (OTCPK:AITX), today announced that its wholly owned subsidiary, Robotic Assistance Devices, Inc. (RAD) has received pre-order commitments for thirty of the Company's recently announced RIO, portable, solar-powered security solution.
RIO (ROSA Independent Observatory) continues the productization of RAD's best-selling, multiple award-winning security robot known as ROSA. RIO consists of a single ROSA 3.1 unit mounted atop a solar-powered portable trailer, with the option of adding a second ROSA unit.
"Leading up to RIO's formal announcement earlier this week at GSX, we launched a pre-order program exclusively for our authorized dealers and select clients," said Mark Folmer, President at RAD. "The response to RIO prior to GSX was impressive, but once our dealers and their clients saw RIO up close at the show it became quite clear that interest in RIO would exceed our expectations. Clients were pleasantly surprised to learn that RIO included such advanced functionality, and priced well below what they would usually pay."
RAD exhibited at GSX 2022 in Atlanta which concluded Wednesday. On display at the security industry trade show were RIO, several ROSAs and AVA.
"RIO has quickly become RAD's most successful product announcement to date," said Steve Reinharz, CEO of AITX and RAD. "Everything adds up with RIO, it's a lower cost alternative to inferior legacy solutions. I expect RIO to help post some impressive recurring revenue numbers for the Company. We have a winner in RIO," Reinharz concluded.
"The response was so strong at GSX that we've decided to extend the RIO pre-order program through the month of September," Folmer added. "This extension will give many of the new dealers and end-users we met this week time to take advantage of the extra incentives in the RIO pre-order program."
RIO has been designed with portability and round-the-clock performance in mind. RIO is completely self-contained as well as self-sufficient. All components necessary to provide day and nighttime security and surveillance are included with RIO. All networking hardware and software is provided, including RAD's 'optimized cellular' connectivity. At its base stands a ruggedized portable trailer positioning the unit's two solar panels and housing the device's high-performance batteries and control systems. RIO's retractable mast extends nearly 20' where a single ROSA is mounted providing an ideally positioned 180° field of view through its two high resolution PTZ cameras. To achieve a 360° field of view, a ROSA-Expander unit is also available.
RAD expects to make additional announcements of recently signed authorized dealers and additional sales updates in the immediate future.
RAD's parent company AITX has filed for uplisting to the OTCQB. Future announcements will be made regarding the status of the OTCQB application.
ROSA is a multiple award-winning, compact, self-contained, portable, security and communication solution that can be deployed in about 15 minutes. Like other RAD solutions, a stand-alone ROSA only requires power, which is provided when configured along with RIO, as it includes all necessary communications hardware. ROSA's AI-driven security analytics include human, firearm, vehicle detection, license plate recognition, responsive digital signage and audio messaging, and complete integration with RAD's software suite notification and autonomous response library. Two-way communication is optimized for cellular, including live video from ROSA's dual high-resolution, full-color, always-on cameras. RAD has published two Case Studies detailing how ROSA has helped eliminate instances of theft, trespassing and loitering at car rental locations and construction sites across the country.
Robotic Assistance Devices (RAD) is a high-tech start-up that delivers robotics and artificial intelligence-based solutions that empower organizations to gain new insight, solve complex security challenges, and fuel new business ideas at reduced costs. RAD developed its advanced security robot technology from the ground up including circuit board design, and base code development. This allows RAD to have complete control over all design elements, performance, quality, and the user's experience of all security robots whether SCOT, ROSA, Wally, Wally HSO, AVA, ROAMEO, CASSIE, RIO, or RAD Light My Way. Read about how RAD is reinventing the security services industry by downloading the Autonomous Remote Services Industry Manifesto, and request a copy of the recently published 'Navigating the New Economy: Jobs & Automation, Challenges & Opportunities'.
CAUTIONARY DISCLOSURE ABOUT FORWARD-LOOKING STATEMENTS
This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Statements in this news release other than statements of historical fact are "forward-looking statements" that are based on current expectations and assumptions. Forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from those expressed or implied by the statements, including, but not limited to, the following: the ability of Artificial Intelligence Technology Solutions to provide for its obligations, to provide working capital needs from operating revenues, to obtain additional financing needed for any future acquisitions, to meet competitive challenges and technological changes, to meet business and financial goals including projections and forecasts, and other risks. No information contained in this news release should be construed as any indication whatsoever of the Company's future stock price, revenues, or results of operations. Additionally, industry data provided herein is of no predictive value regarding the future sale of the Company's products. Artificial Intelligence Technology Solutions undertakes no duty to update any forward-looking statement(s) and/or to confirm the statement(s) to actual results or changes in Artificial Intelligence Technology Solutions expectations.
About Artificial Intelligence Technology Solutions (AITX)
AITX is an innovator in the delivery of artificial intelligence-based solutions that empower organizations to gain new insight, solve complex challenges and fuel new business ideas. Through its next-generation robotic product offerings, AITX's RAD, RAD-M and RAD-G companies help organizations streamline operations, increase ROI, and strengthen business. AITX technology improves the simplicity and economics of patrolling and guard services and allows experienced personnel to focus on more strategic tasks. Customers augment the capabilities of existing staffs and gain higher levels of situational awareness, all at drastically reduced cost. AITX solutions are well suited for use in multiple industries such as enterprises, government, transportation, critical infrastructure, education, and healthcare. To learn more, visit http://www.aitx.ai, http://www.stevereinharz.com, http://www.radsecurity.com and http://www.radlightmyway.com, or follow Steve Reinharz on Twitter @SteveReinharz.
###
Steve Reinharz
949-636-7060
@SteveReinharz
$PVSP Update
$PVSP Q: What does it take to bring a new product to market? Or all products when you enter a new market? Don't you just grow a few plants after all?
— Pervasip Corp (@PervasipC) September 12, 2022
$HWAL..About 4 times avg volume and up 12%-don’t sleep on this one!
$PVSP Announced $1.6 Million in August Revenues and 3rd Quarter Guidance https://finance.yahoo.com/news/pervasip-announces-1-6-million-131500755.html?soc_src=social-sh&soc_trk=tw&tsrc=twtr via @YahooFinance
$PVSP The cannabis market on the west coast is still challenged by its post Covid dip, massive oversupply, and egregious tax and state by state rules, brands like ArtizenTM, well-oiled distribution, top notch management teams and healthy, transparent financial structures, will be the ultimate winners in this space.
https://www.marketwatch.com/press-release/restructuring-leading-to-500000-in-annual-cost-savings-plus-new-customer-contracts-2022-08-04?mod=mw_quote_news_seemore
$PVSP $1.6 Million in August Revenues and 3rd Quarter Guidance https://www.marketwatch.com/press-release/pervasip-announces-16-million-in-august-revenues-and-3rd-quarter-guidance-2022-09-13?reflink=mw_share_twitter
$PVSP Sept. 13, 2022 (GLOBE NEWSWIRE) -- Pervasip Corp. (OTC: PVSP) (“Pervasip” or the “Company”), a developer of companies and technologies in high value emerging markets, together with Zen Asset Management, today announced that Artizen reached sales of $1.6 million in August.
“Marking the best sales month ever is a testament to the hard work of the team and quality of Artizen branded products in these difficult market conditions,” says German Burtscher, Pervasip’s CEO. “August also marks the close of the 3rd quarter and the restructuring efforts of the last several months are starting to show improvement across many key financial performance indicators, including cashflow for Q3. As we further rationalize our business, including shedding of underperforming assets, we will continue to prioritize margins over revenue to build lasting financial health and strengthening fundamentals important to support our growth. We are achieving a more balanced ratio of revenues across all product categories which will serve the Company well as it goes into Q4.”
The Company also reports that various new product lines and planned near-term acquisitions will add revenue, new growth opportunities, and be a springboard for expansion into other recreational cannabis markets in the US.
$PVSP news getting big buzz: Pervasip Announces $1.6 Million in August Revenues and 3rd Quarter Guidance https://finance.yahoo.com/news/pervasip-announces-1-6-million-131500755.html?soc_src=social-sh&soc_trk=tw&tsrc=twtr via @YahooFinance
$PVSP Located in beautiful Port Townsend, on the northern end of the Olympic Peninsula, this gorgeous light deprivation greenhouse garden is producing beautiful flower and is home to some of the more exotic genetics in the Artizen brand. At 39,000 square feet it is the second largest of all of the gardens growing Artizen branded flower.
$PVSP in beautiful Port Townsend, on the northern end of the Olympic Peninsula, this gorgeous light deprivation greenhouse garden is producing beautiful flower and is home to some of the more exotic genetics in the Artizen brand. At 39,000 square feet it is the second largest of all of the gardens growing Artizen branded flower.
$PVSP ZAM is a diversified asset management company, founded to acquire, develop, and support companies
$PVSP Company reported record sales in August and has plans for new product line and NEAR-TERM ACQUISITIONS for further growth!
$PVSP We also invested in a small Korea based research entity, KRTL, to establish an early foothold in the $PVSP $KRTL
$PVSP Update
$PVSP Q: What does it take to bring a new product to market? Or all products when you enter a new market? Don't you just grow a few plants after all?
— Pervasip Corp (@PervasipC) September 12, 2022
$IVDN Latest News and Headlines: https://www.barchart.com/stocks/quotes/IVDN/news
$CYCA News: Cytta Corp Completes Sale And Deployment Of Newly Released Igan 2.0 To The DFW Airport Department Of Public Safety
https://www.accesswire.com/716136/Cytta-Corp-Completes-Sale-And-Deployment-Of-Newly-Released-Igan-20-To-The-DFW-Airport-Department-Of-Public-Safety
$PVSP the mature markets provide relevant insights into future sales distribution across key categories with flower and pre-rolls still leading at 59%, followed by concentrates (dabs/vape) at 29% and finally edibles and beverages at a combined 9%
Artizen brands will materially expand their flower market share and enter the concentrates and edibles market with a goal of occupying top 10% market share positions in each vertical.
$PVSP will expand flower and concentrates offerings within our brands as well as adding new brands for certain product offerings and price points through Q1 2023.
$PVSP Pervasip/Artizen Corp plans to expand its national reach by adding various recreational states to its brand footprint, either via licensing agreements or through acquisitions of recreational cultivation and retail licenses
95% of revenue from Artizen’s brands has come from sales of cannabis flower, supporting its position of the 9th most sold independent flower brand in North America; acquisitions and partnerships will open access to concentrates and edible verticals representing 40% of market sales and heretofore not covered by Artizen products
Artizen projects it will generate $50 million in annualized revenues nationally by end of Q4 2024; this is a conservative estimate that does not include any potential revenue multiples from acquisition of retail opportunities.
24 Months plan detail
Rename Pervasip Corp to Artizen Corporation by year end 2022 to better reflect the new focus of the company
Change the OTC ticker symbol
Re-brand all Pervasip/Artizen assets
Continue to rationalize the business through Q1 2023 with a focus on operating margins, shedding underperforming assets, consolidating operations and focus in-house talent on higher margin operations and product lines
Acquire concentrates assets by end of 2022, launching into the highly lucrative concentrates business
Expand flower and concentrates offerings within our brands as well as adding new brands for certain product offerings and price points through Q1 2023
Complete the audit and begin the OTC QB application process during Q2 2023
Launch Artizen Wellness Q2 2023
Enter the edibles market in Q2 2023 via acquisition and partnerships
Artizen becomes an MSO with cultivation and retail assets in 1 – 2 additional states during 2nd half of 2024, beginning its state expansion in Q1 2023, initially through brand licensing opportunities and strategic partnerships, and eventually via acquisitions and mergers during Q3 and Q4 2024
Close first brand licensing agreement by end of Q4 2022
Close one brand licensing deal every quarter thereafter
Financial Outlook Q3 2022 through Q4 2023
Reach $2.0 million in monthly revenue by end of Q1 2023
Reach $2.5 million or $30 million in annualized revenue by end of Q4 2023 with 30% in adjusted EBIDTA
Reach $3.0 million or $36 million in annualized revenues by end of Q2 2024 with 35% in adjusted EBIDTA
Reach $50 million in annualized revenue with 35% in adjusted EBIDTA
$PVSP (OTC: PVSP) (“Pervasip” or the “Company”), a developer of companies and technologies in high value emerging markets, together with Zen Asset Management today announced its 2-year strategic roadmap.
“On the heels of Artizen Corporation’s reverse merger to acquire Pervasip Corp, the cannabis industry experienced a dramatic post pandemic contraction. Planned restructuring efforts had already launched in late 2021 and we took even more aggressive steps to further rationalize our business, dispose of undervalued assets, re-focus on higher margin products and allowed our leading brands to take a more aggressive posture to increase market share. Healthy inventory amounts provided for extraordinary financing via cashflow, albeit at extremely low margins, a carefully considered short term decision which has now come to an end as we have achieved our goals. All these efforts position us nicely for healthy financial growth in 2023. As promised, we have also finalized a 24-month roadmap and are in a position to provide carefully considered guidance in a market that is still extremely unpredictable,” said German Burtscher, Pervasip CEO. “It is also important to note that all the Artizen brands’ revenue is wholesale, revenue derived from sales to retailers. The vast majority of MSOs report revenues and resulting financials that include retail sales from stores they own in addition to usually rather small wholesale revenue, all mostly generated in protected markets. Washington State (WA) cannabis sales are taxed at 47% (!) and each dollar sold by a producer/processor is marked up 3 – 3.5 times by the retailers they sell to. Generating profitable revenue in WA will translate extremely well once our brands and operating expertise is applied in other recreational markets.”
Market Overview – Washington
The below Washington State (WA) sales by category chart provides information on how monthly sales of approximately $100 million in retail sales breaks down by product category. It might also be informative to understand that June ’22 sales over June ’19 sales (pre pandemic) show an almost 17% increase. While WA sales are slightly above other mature cannabis states (NV, CO, OR), similar increases can be seen in those markets. An exuberant pandemic triggered belief in continued rapid growth has led to over development of production infrastructure and resulted in material oversupply of bulk cannabis flower. The market is in the process of correcting and the Company estimates Q3 2023 being the end of the corrective period, resulting in strengthening prices.
$100M In Monthly Sales By Category
After several years of recreational sales, the mature markets provide relevant insights into future sales distribution across key categories with flower and pre-rolls still leading at 59%, followed by concentrates (dabs/vape) at 29% and finally edibles and beverages at a combined 9%
Artizen brands will materially expand their flower market share and enter the concentrates and edibles market with a goal of occupying top 10% market share positions in each vertical.
Strategic Outlook Summary through Q4 2024
Focus on expanding its Washington State footprint, strengthening its brand repertoire and aggressively expanding its product lineup
We expect in-state revenues generated by all brands and across all product categories to reach $30 million in annualized revenue by end of Q4 2024 with Gross Margins reaching 40% and an adjusted EBIDTA of 30%
Pervasip/Artizen Corp plans to expand its national reach by adding various recreational states to its brand footprint, either via licensing agreements or through acquisitions of recreational cultivation and retail licenses
95% of revenue from Artizen’s brands has come from sales of cannabis flower, supporting its position of the 9th most sold independent flower brand in North America; acquisitions and partnerships will open access to concentrates and edible verticals representing 40% of market sales and heretofore not covered by Artizen products
Artizen projects it will generate $50 million in annualized revenues nationally by end of Q4 2024; this is a conservative estimate that does not include any potential revenue multiples from acquisition of retail opportunities.
24 Months plan detail
Rename Pervasip Corp to Artizen Corporation by year end 2022 to better reflect the new focus of the company
Change the OTC ticker symbol
Re-brand all Pervasip/Artizen assets
Continue to rationalize the business through Q1 2023 with a focus on operating margins, shedding underperforming assets, consolidating operations and focus in-house talent on higher margin operations and product lines
Acquire concentrates assets by end of 2022, launching into the highly lucrative concentrates business
Expand flower and concentrates offerings within our brands as well as adding new brands for certain product offerings and price points through Q1 2023
Complete the audit and begin the OTC QB application process during Q2 2023
Launch Artizen Wellness Q2 2023
Enter the edibles market in Q2 2023 via acquisition and partnerships
Artizen becomes an MSO with cultivation and retail assets in 1 – 2 additional states during 2nd half of 2024, beginning its state expansion in Q1 2023, initially through brand licensing opportunities and strategic partnerships, and eventually via acquisitions and mergers during Q3 and Q4 2024
Close first brand licensing agreement by end of Q4 2022
Close one brand licensing deal every quarter thereafter
Financial Outlook Q3 2022 through Q4 2023
Reach $2.0 million in monthly revenue by end of Q1 2023
Reach $2.5 million or $30 million in annualized revenue by end of Q4 2023 with 30% in adjusted EBIDTA
Reach $3.0 million or $36 million in annualized revenues by end of Q2 2024 with 35% in adjusted EBIDTA
Reach $50 million in annualized revenue with 35% in adjusted EBIDTA
$PVSP Our focus is on developing and investing in companies and technologies in high value emerging markets, specifically Cannabis and Medical Fungi. We look for investments in operators who will become the foundational base for growth in each segment and related technologies and research assets that can support near term and future expansion.
https://www.pervasip.net/about
Followers
|
351
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
29933
|
Created
|
03/26/14
|
Type
|
Free
|
Moderator RichDude | |||
Assistants Let's Roll Value_Investor ChrisTianSurfer jedijazz fast.money BLULLISH |
Posts Today
|
0
|
Posts (Total)
|
29933
|
Posters
|
|
Moderator
|
|
Assistants
|
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |